Oxford Asset Management LLP Invests $879,000 in HCA Healthcare, Inc. (NYSE:HCA)

Oxford Asset Management LLP acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,930 shares of the company's stock, valued at approximately $879,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Galvin Gaustad & Stein LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $18,044,000. NRI Wealth Management LC bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $2,896,000. Czech National Bank lifted its holdings in HCA Healthcare by 4.5% in the fourth quarter. Czech National Bank now owns 39,543 shares of the company's stock worth $11,869,000 after buying an additional 1,691 shares during the period. Peak Financial Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $1,122,000. Finally, Wedge Capital Management L L P NC boosted its holdings in HCA Healthcare by 7.7% in the fourth quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company's stock worth $34,840,000 after acquiring an additional 8,329 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Guggenheim initiated coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Price Performance

NYSE HCA traded down $0.29 on Thursday, hitting $344.79. The stock had a trading volume of 541,704 shares, compared to its average volume of 1,394,345. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market capitalization of $84.89 billion, a price-to-earnings ratio of 15.68, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The firm has a 50-day moving average of $331.02 and a 200-day moving average of $331.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.36 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is currently 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.